HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuji Tsuruta Selected Research

Pharmaceutical Preparations

6/2002A novel anti-fibrotic agent pirfenidone suppresses tumor necrosis factor-alpha at the translational level.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuji Tsuruta Research Topics

Disease

1Neoplasms (Cancer)
07/2004
1Colorectal Neoplasms (Colorectal Cancer)
07/2004
1Hemophilia A (Haemophilia)
08/2003
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
04/2003
1Shock
06/2002
1Septic Shock (Toxic Shock Syndrome)
06/2002
1Fibrosis (Cirrhosis)
06/2002
1Inflammation (Inflammations)
06/2002

Drug/Important Bio-Agent (IBA)

3CytokinesIBA
07/2004 - 06/2002
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
08/2003 - 04/2003
2pirfenidoneIBA
06/2002 - 06/2002
2Interleukin-10 (Interleukin 10)IBA
06/2002 - 06/2002
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2002 - 06/2002
1Neoplasm Antigens (Tumor Antigens)IBA
07/2004
1Interleukin-4 (Interleukin 4)IBA
07/2004
1Factor VIII (Coagulation Factor VIII)IBA
08/2003
1AntigensIBA
08/2003
1alpha-beta T-Cell Antigen Receptors (T-Cell Receptor alpha-Chain)IBA
04/2003
1GalactosamineIBA
06/2002
1Pharmaceutical PreparationsIBA
06/2002
1Therapeutic UsesIBA
06/2002
1Interleukin-6 (Interleukin 6)IBA
06/2002
1Interferon-gamma (Interferon, gamma)IBA
06/2002
1LipopolysaccharidesIBA
06/2002
1Proteins (Proteins, Gene)FDA Link
06/2002

Therapy/Procedure

1Therapeutics
08/2003
1Oral Administration
06/2002